This inventor holds 3 USPTO granted patents. Top assignee: Biochem Pharma Inc.. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2004
Title: Arshad Siddiqui: Innovator in Antiviral Treatments
Introduction
Arshad Siddiqui is a notable inventor based in Dollard des Ormeaux, Canada. He has made significant contributions to the field of antiviral treatments, particularly focusing on flavivirus infections. With a total of 3 patents to his name, Siddiqui's work is paving the way for new therapeutic methods.
Latest Patents
One of his latest patents is a method for the treatment or prevention of flavivirus infections using nucleoside analogues. This invention relates to administering a therapeutically effective amount of a compound having a specific formula or a pharmaceutically acceptable salt thereof. Another significant patent involves novel [1,8] naphthyridine derivatives that exhibit antiviral activity, specifically targeting the hepatitis C virus.
Career Highlights
Arshad Siddiqui is currently associated with Biochem Pharma Inc., where he continues to innovate in the field of pharmaceuticals. His research and inventions are crucial in developing effective treatments for viral infections.
Collaborations
Siddiqui has worked alongside talented colleagues such as Benoit Bachand and Nghe Nguyen-Ba, contributing to a collaborative environment that fosters innovation and research.
Conclusion
Arshad Siddiqui's work in antiviral treatments showcases his dedication to improving healthcare through innovative solutions. His patents reflect a commitment to addressing significant medical challenges, particularly in the realm of viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile